A phase 3 trial investigating TG-4010 in the treatment of non-small cell lung cancer.

Trial Profile

A phase 3 trial investigating TG-4010 in the treatment of non-small cell lung cancer.

Planning
Phase of Trial: Phase III

Latest Information Update: 10 Feb 2015

At a glance

  • Drugs TG 4010 (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Transgene
  • Most Recent Events

    • 10 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top